← Back to Blog
Instruments and Equipments Last updated on May 20, 2026 By askmicro 1 min read

Laminar FloLaminar Flo w Hoods in Pharmacy: Ensuring Sterile Environments for Microbial Handling

Why Laminar Flow Matters in Compounding Pharmacies The U.S. Pharmacopeia USP  requires ISO Class 5 air for sterile compounding. Laminar flow hoods achieve this...

In This Article 6 sections
  1. 1 Why Laminar Flow Matters in Compounding Pharmacies
  2. 2 Horizontal vs. Vertical Laminar Flow
  3. 3 Key Performance Metrics
  4. 4 Best Practices for Microbial Handling
  5. 5 Common Pitfalls
  6. 6 Conclusion

Why Laminar Flow Matters in Compounding Pharmacies

The U.S. Pharmacopeia USP <797> requires ISO Class 5 air for sterile compounding. Laminar flow hoods achieve this by delivering air with less than 100 particles ≥0.5 µm per cubic foot.

Horizontal vs. Vertical Laminar Flow

  • Horizontal: Air exits the HEPA filter toward the operator—ideal for non‑hazardous preparations.
  • Vertical: Air flows downward, protecting the operator from cytotoxic aerosols; recommended for hazardous drugs per USP <800>.

Key Performance Metrics

ParameterUSP RequirementBest‑in‑Class Hood
Air Velocity0.45 m/s ± 20%0.47 m/s (±10%)
HEPA Efficiency>99.97% @ 0.3 µm99.995% @ 0.12 µm
Noise Level<68 dB(A)55 dB(A)

Best Practices for Microbial Handling

  1. Disinfect work surfaces with 70% IPA every 30 minutes during compounding.
  2. Change pre‑filters monthly; clogged filters raise particle counts by up to 300%.
  3. Perform smoke‑pattern tests semi‑annually to visualize airflow integrity.
  4. Use UV‑C decontamination cycles overnight to achieve a >4‑log reduction in surface bioburden.

Common Pitfalls

Placing paperwork upstream of critical work areas can increase colony‑forming units (CFU) by 15–20 CFU/plate in settle‑plate tests. Always keep non‑sterile items downstream of product flow.

Conclusion

Well‑maintained laminar flow hoods reduce contamination events by 98%, safeguarding patient safety and pharmacy reputation.

References: USP <797> (2024 Revision); International Journal of Pharmaceutical Compounding 2023, 27(4): 312‑318.

Share this article: